Given the downregulation of RUNX3 expression in CBF AML patients, and to fully assess its importance in normal human myeloid development, the effects of RUNX3 KD in cell growth and differentiation were further determined. This evidence concerns the gene CEBPZ and acute myeloid leukemia.